Evidence map›Paper›PMID 26369931›Full record

ArticleBiology open2015

A zebrafish model of inflammatory lymphangiogenesis.

Kazuhide S Okuda, June Pauline Misa, Stefan H Oehlers, Christopher J Hall, Felix Ellett, Sultan Alasmari, Graham J Lieschke, Kathryn E Crosier, Philip S Crosier, Jonathan W Astin

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Neutrophils in tumor- and inflammation-induced lymphangiogenesis.International journal of biological sciences · 2025
    Review
  5. Review
  6. Article
  7. International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dietary Inclusion of Seabuckthorn (Frontiers in physiology · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. From Species to Regional and Local Specialization of Intestinal Macrophages.Frontiers in cell and developmental biology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Kazuhide S OkudaDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
June Pauline MisaDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Stefan H OehlersDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham 27710, USA.
Christopher J HallDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Felix EllettAustralian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.
Sultan AlasmariAustralian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.
Graham J LieschkeAustralian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.
Kathryn E CrosierDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Philip S CrosierDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Jonathan W AstinDepartment of Molecular Medicine & Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand j.astin@auckland.ac.nz.
University of Auckland · NZAustralian Regenerative Medicine Institute · AUDuke University · USMonash University · AU

Funding

ZEBRAFISH INTERNATIONAL RESOURCE CENTERP40RR012546 · NCRR · UNIVERSITY OF OREGON · PI WESTERFIELD, MONTE · 1998 to 2011
$21.9M
NCRR NIH HHS P40 RR012546
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a disabling chronic inflammatory disease of the gastrointestinal tract. IBD patients have increased intestinal lymphatic vessel density and recent studies have shown that this may contribute to the resolution of IBD. However, the molecular mechanisms involved in IBD-associated lymphangiogenesis are still unclear. In this study, we established a novel inflammatory lymphangiogenesis model in zebrafish larvae involving colitogenic challenge stimulated by exposure to 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sodium sulphate (DSS). Treatment with either TNBS or DSS resulted in vascular endothelial growth factor receptor (Vegfr)-dependent lymphangiogenesis in the zebrafish intestine. Reduction of intestinal inflammation by the administration of the IBD therapeutic, 5-aminosalicylic acid, reduced intestinal lymphatic expansion. Zebrafish macrophages express vascular growth factors vegfaa, vegfc and vegfd and chemical ablation of these cells inhibits intestinal lymphatic expansion, suggesting that the recruitment of macrophages to the intestine upon colitogenic challenge is required for intestinal inflammatory lymphangiogenesis. Importantly, this study highlights the potential of zebrafish as an inflammatory lymphangiogenesis model that can be used to investigate the role and mechanism of lymphangiogenesis in inflammatory diseases such as IBD.

Indexed as

InflammationInflammatory bowel diseaseLymphaticZebrafish

Identifiers

PMID26369931
PMCPMC4610225
OpenAlexW2336626280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.